forum

BLISSGVS Share Price Discussion

Bliss GVS Pharma Ltd.
Sector: Pharmaceuticals and health care
... Read more
BLISSGVS Share Price *
109.1 +0.05 (0.05%)
* (quote may be delayed)

BLISSGVS Discussion Forum

  • BLISSGVS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,855.28
    Enterprise Value1,828.99
    Price to Earnings35.33
    Price to Book Value3.08
    Return on Capital Employed0.15
    Return on Equity0.11
    Face Value1
    Dividend Yield0.01
  • BLISSGVS Share Price - Technicals

    keyboard_arrow_down
    BLISSGVS - 52 Week High₹197
    BLISSGVS - 52 Week Low₹73.75
  • BLISSGVS - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    15-Mar-18Choice Equity BrokingBuy235.5
    9-Jan-18Joindre Capital ServicesBuy350
    27-Dec-17Choice Equity BrokingBuy262.5
    View all BLISSGVS - Share Targets - Broker Reports
  • BLISSGVS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 16108.4110108.3109.2
    Sep 13115115.6107.8109.05
    Sep 12112113.4108.5110.25
    Sep 11109.95113107.5112.05
    Sep 9109.75109.75107.5108.05
  • BLISSGVS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹100.69
    30 Day Moving Average₹101
    50 Day Moving Average₹123.38
    100 Day Moving Average₹142.93
    200 Day Moving Average₹152.33
  • BLISSGVS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue298349.18-0.15
    Operating Profit8991.75-0.03
    Profit Before Tax8798.42-0.12
    Net Income5762.6-0.09
  • BLISSGVS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds6035410.11
    Total Liabilities132153-0.14
    Total Assets7366940.06
  • BLISSGVS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity2334.79-0.34
    Cash from Investing Activity22-26.56-1.83
    Cash from Financing Activity-22-13.850.59
    Net Cash Flow23-5.63-5.09
  • BLISSGVS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.080.1
    Return on Equity0.110.13
    Return on Capital Employed0.150.2
  • BLISSGVS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.05
    3 Year CAGR Growth in Operating Profit0.03
    3 Year CAGR Growth in EBIDTA-0.07
    3 Year CAGR Growth in Net Income-0.05
    3 Yr CAGR Growth - Diluted EPS-0.05
  • BLISSGVS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.16
    5 Year CAGR Growth in Operating Profit-0.12
    5 Year CAGR Growth in EBIDTA-0.14
    5 Year CAGR Growth in Net Income0.01
    3 Yr CAGR Growth - Diluted EPS0.01
  • BLISSGVS Share Price - Recent News

    keyboard_arrow_down
  • BLISSGVS - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.